This notion is mainly based on the hypothesis that obesity per se increases inflammation, i.e., proinflammatory cytokines like IL-1β and IL-6 due to an increased leakiness of the gut barrier in obese individuals [33–36]. Here, IL1B is linked to obesity due to melanocortin 4 receptor deficiency.